This article highlights five myths about treatment for OUD, provides context regarding current guidance, and offers suggestions for how managed care organizations (MCOs) can support care for patients with addiction through a chronic health model.
This sponsored webinar explores the evolution of the treatment landscape, goals of treatment, and managed care considerations in Chronic Lymphocytic Leukemia (CLL) and provides an update on the new clinical data and real-world evidence for a targeted therapy in the treatment of patients living with CLL.
Nonalcoholic steatohepatitis or NASH is a form of Nonalcoholic fatty liver disease or NAFLD, in which the liver is inflamed and damaged due to the buildup of fat in the liver.
The rebate system is an important lever for ensuring the affordability of prescription medications and health care premiums for Americans. AMCP supports the use of a rebate system as one of many levers to help to control drug costs.
Managed care pharmacy and prescription drug coverage is a growing part of the American health care sector. AMCP launched the annual Access, Affordability, and Outcomes report to raise awareness of the existence, prevalence, and importance of managed care pharmacy.
Schizophrenia is a mental disorder that can be characterized by disruptions in a person's thought process, perception, responsiveness, and interactivity.